Browse > Article

Dose-Response Relationship of Avian Influenza Virus Based on Feeding Trials in Humans and Chickens  

Pak, Son-Il (College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University)
Lee, Jae-Yong (National Veterinary Research and Quarantine Service)
Jeon, Jong-Min (National Veterinary Research and Quarantine Service)
Publication Information
Journal of Veterinary Clinics / v.28, no.1, 2011 , pp. 101-107 More about this Journal
Abstract
This study aimed to determine dose-response (DR) curve of avian influenza (AI) virus to predict the probability of illness or adverse health effects that may result from exposure to a pathogenic microorganism in a quantitative microbial risk assessment. To determine the parametric DR relationship of several strains of AI virus, 7 feeding trial data sets challenging humans (5 sets) and chickens (2 sets) for strains of H3N2 (4 sets), H5N1 (2 sets) and H1N1 (1 set) from the published literatures. Except for one data set (study with intra-tracheal inoculation for data set no. 6), all were obtained from the studies with intranasal inoculation. The data were analyzed using three types of DR model as the basis of heterogeneity in infectivity of AI strains in humans and chickens: exponential, beta-binomial and beta-Poisson. We fitted to the data using maximum likelihood estimation to get the parameter estimates of each model. The alpha and beta values of the beta-Poisson DR model ranged 0.06-0.19 and 1.7-48.8, respectively for H3N2 strain. Corresponding values for H5N1 ranged 0.464-0.563 and 97.3-99.4, respectively. For H1N1 the parameter values were 0.103 and 12.7, respectively. Using the exponential model, r (infectivity parameter) ranged from $1.6{\times}10^{-8}$ to $1.2{\times}10^{-5}$ for H3N2 and from $7.5{\times}10^{-3}$ to $4.0{\times}10^{-2}$ for H5N1, while the value was $1.6{\times}10^{-8}$ for H1N1. The beta-Poisson DR model provided the best fit to five of 7 data sets tested, and the estimated parameter values in betabinomial model were very close to those of beta-Poisson. Our study indicated that beta-binomial or beta-Poisson model could be the choice for DR modeling of AI, even though DR relationship varied depending on the virus strains studied, as indicated in prior studies. Further DR modeling should be conducted to quantify the differences among AI virus strains.
Keywords
avian influenza virus; dose-response model; risk assessment;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Spekreijse D, Bouma A, Stegeman JA, Koch G, de Jong MC. The effect of inoculation dose of a highly pathogenic avian influenza virus strain H5N1 on the infectiousness of chickens. Vet Microbiol 2011; 147: 59-66.   DOI
2 Swayne DE. Occupational and consumer risks from avian influenza viruses. Dev Biol (Basel) 2006; 124: 85-90.
3 Snyder MH, Clements ML, Betts RF, Dolin R, Buckler-White AJ, Tierney EL, Murphy BR. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J Clin Microbiol 1986; 23: 852-857.
4 Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72: 7367-7373.
5 Soller JA. Use of microbial risk assessment to inform the national estimate of acute gastrointestinal illness attributable to microbes in drinking water. J Wat Health 2006; 4: 165-186.   DOI   ScienceOn
6 Nguyen DC, Uyeki TM, Jadhao S, Maines T, Shaw M, Matsuoka Y, Smith C, Rowe T, Lu X, Hall H, Xu X, Balish A, Klimov A, Tumpey TM, Swayne DE, Huynh LP, Nghiem HK, Nguyen HH, Hoang LT, Cox NJ, Katz JM. Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol 2005; 79: 4201-4212.   DOI   ScienceOn
7 Schijven JF, Teunis PFM, de Roda Husman AM. Quantitative risk analysis of avian influenza virus infection in water. RIVM report, 2005.
8 Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, Kawaoka Y, Kodihalli S, Krauss S, Markwell D, Murti KG, Norwood M, Senne D, Sims L, Takada A, Webster RG. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998; 252: 331-342.   DOI   ScienceOn
9 McBride G, Till D, Ryan T, Ball A, Lewis G, Palmer S, Weinstein P. Freshwater Microbiology research programme report: pathogen occurrence and human health risk assessment analysis. Ministry of Health, New Zealand, 2002.
10 Holcomb DL, Smith MA, Ware GO, Hung Y, Brackett RE, Doyle MP. Comparison of six dose-response models for use with food-borne pathogens. Risk Anal 1999; 19: 1091-1100.
11 Haas CN, Rose JB, Gerba CP. Quantitative microbial risk assessment. New York: Wiley. 1999: 260-319.
12 Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999; 73: 5903-5911.
13 FSIS. Interagency risk assessment for the public health impact of highly pathogenic avian influenza virus in poultry, shell eggs, and egg products. 2010.
14 Haas CN. Estimation of risk due to low-doses of microorganisms - a comparison of alternative methodologies. Am J Epidemiol 1983; 118: 573-582.
15 Brown JD, Stallknecht DE, Valeika S, Swayne DE. Susceptibility of wood ducks to H5N1 highly pathogenic avian influenza virus. J Wildl Dis 2007; 43: 660-667.
16 Hinshaw VS, Webster RG, Easterday BC, Bean WJ Jr. Replication of avian influenza A viruses in mammals. Infect Immun 1981; 34: 354-361.
17 Clements ML, Sears SD, Christina K, Murphy BR, Snyder MH. Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors. J Clin Microbiol 1989; 27: 219-222.
18 de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH, Farrar J. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352: 686-691.   DOI   ScienceOn
19 Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML. Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol 2000; 74: 1443-1450.   DOI   ScienceOn
20 Clements ML, Snyder MH, Buckler-White AJ, Tierney EL, London WT, Murphy BR. Evaluation of avian-human reassortant influenza A/Washington/897/80x A/Pintail/119/79 virus in monkeys and adult volunteers. J Clin Microbiol 1986; 24: 47-51.
21 Capua I, Alexander DJ. Avian influenza and human health. Acta Trop 2002; 83: 1-6.
22 Zmirou-Navier D, Gofti-Laroche L, Hartemann P. Waterborne microbial risk assessment: a population-based dose-response function for Giardia spp. (E.MI.R.A study). BMC Public Health 2006; 6: 122.   DOI
23 Clements ML, O'Donnell S, Levine MM, Chanock RM, Murphy BR. Dose response of A/Alaska/6/77 (H3N2) coldadapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect Immun 1983; 40: 1044-1051.
24 Teunis P, Havelaar A. The beta poisson dose-response models is not a single hit model. Risk Anal 2000; 20: 513-520.   DOI   ScienceOn